Elisabeth Bloemena - Curriculum Vitae

1992 - 1996 Pathology trainee. Dept of Pathology, Free University, Amsterdam
(head: prof.dr. C.J.L.M. Meijer)
1975 - 1983 Medical School, University of Amsterdam, Amsterdam
Professional experience:
2010 - present MSRC - plaatsvervangend opleider voor de pathologie VUmc
2003 - present Professor of Oral Pathology
1996 - present Staff member (pathologist), Dept of Pathology, VU University medical centre, Amsterdam
(head: prof.dr. C.J.L.M. Meijer)
1190 - 1992 Post doc fellow, Dept of Pathology, VU University medical centre, Amsterdam
(head: prof.dr. C.J.L.M. Meijer).
Subject: active specific immunotherapy in patients with colon carcinoma, Dukes B and C
1989 -1990 Post doc fellow, Dept of Immunology Academic Medical Centre, Amsterdam
(head. dr.T.A. Out).
Subject: In vivo monitoring of cytokines in kidney transplant recipients
1984 - 1988 Research fellow, Dept of Clinical Immunobiology, Central Laboratory of the Dutch Blood Transfusion Service, Amsterdam
(head: dr. W.P. Zeijlemaker).
Thesis: immunosuppressive effects of prednisolone and cyclosporin A
1984 Assistant research fellow, Dept Tumorbiology, National Cancer Institute
(head: prof.dr. Ph. Rumke).
Research experience:
Augustus 1990 - January 1992 phase III clinical trial: active specific immunisation in patients with Dukes' B and C colon carcinoma.
Trial coördinator: dr. J. Vermorken
jJanuary 1989 - April 1990 post-doc research project: cytokines in serum and urine odrenal transplant patients. Clinical Immunological Laboratory at the Academic Medical Center, Amsterdam.
Supervisor: dr. R.J.M. ten Berge
jJune 1984 - Augustus 1988 PhD thesis: immunosuppressive mechanisms of prednisoloneand -cyclosporin. Dept. of Clinical Immunobiology, Central Laboratory of the Blood Transfusion, Amsterdam.
Supervisor: dr. P.Th.A. Schellekens
Janaury 1984 - April 1984 Monoclonal antibodies and their application in detection of(micro)metastases.
Supervisors: prof. dr. Ph. Rümke, dr. Ph. Hageman, dr. J. Delamarre, Antoni van Leeuwenhoekhuis, Amsterdam
September 1980 - September 1981 Muscle variants in humans (studentproject Anatomy)
Member of editorial board:
  • World Journal of Gastrointestinal Oncology
  • ISRN Gastroenterology
  • Scandinavian Journal of Gastroenterology
Supervisor of Ph.D. students:
  • A.P. Graveland. Molecular diagnosis of minimal residual head and neck cancer and field cancerization.
    VU University, Amsterdam, May 21, 2014.
  • M.M. Rietbergen. The role of human papillomavirus in head and neck cancer.
    VU University, Amsterdam, May 7, 2014
  • A. Turksma. Preclinical studies on immunotherapeutic approaches for the treatment of solid tumors.
    VU University, Amsterdam, November 21, 2013
  • E.R.E.A. Brouns. Oral leukoplakia: a clinical, histopathological and molecular study.
    ACTA, VU University, Amsterdam, June 6 2013
  • H. Vékony. Characterization of slaivary gland tumors
    ACTA, Vrije Universiteit, Amsterdam, The Netherlands. November 2008
  • J. van Beek. EBV carrying gastric carcinomas: a dinstinct clinicopathological entity
    Vrije Universiteit Amsterdam, The Netherlands. October 11, 2005.
  • A. zur Hausen. EBV positive gastric carcinomas: pathogenesis and clinical aspects.
    Vrije Universiteit Amsterdam, The Netherlands. January 7, 2004
  • D.F. Dukers. Immune escape mechanisms and clinicopathological aspects in malignant lymphomas.
    Vrije Universiteit Amsterdam, The Netherlands. November 23, 2001
  • P. Meij. Humoral and cell-mediated immunoe responses directed against Epstein-Barr Virus-encoded tumour-associated proteins.
    Vrije Universiteit Amsterdam The Netherlands. June 27, 2001
  • W.M.C. Mulder. Lymphocytes infiltrating colorectal carcinoma: phenotypical and functional aspects.
    Vrije Universiteit Amsterdam, The Netherlands. May 1, 1996
Member of Ph.D. committee:
  • E. Hoebe. Epstein-Barr virus encoded BARF1 protein: immunopathogenic role, transcriptional regulation and diagnostic use in nasopharyngeal carcinoma.
    VU University, Amsterdam, May 8, 2014.
  • T.C.M.A. Schreuder. Non-alcoholic fatty liver disease (NAFLD): from epidemiology to diagnosis. VU University, Amsterdam December 13, 2012, ISBN978-90-5335-616-6.
  • M. Weijers. Oral squamous cell carcinoma; some epidemiological and clinicopathological aspects. VU University, Amsterdam, October 29, 2012 ISBN 978-90-5335-576-3
  • S.H. Hutajulu. Early Identification of nasopharyngeal carcinoma. VU University Amsterdam, February 17, 2012 ISBN 978-602-8955-98-0.
  • Bremmer, J.F. Molecular diagnosis of oral premalignant disorders. VU University Amsterdam, 19 december 2011.
  • Amaral Mendes, R.A. The keratocystic odontogenic tumor. Clinical behaviour and role of COX-2 in the biological pathways. VU University Amsterdam, 29 april 2010.
  • Dewi K. Paramitra. Diagnostic and protective aspects of humoral immune responses to Epstein-Barr virus encoded protein in nasopharyngeal carcinoma.
    Vrije Universiteit Amsterdam. 09 June 2010.
  • Xander A.F.A. Veenhof. The modern management of rectal cancer. The introduction of laparoscopic techniques.
    Vrije Universiteit Amsterdam. 30 Oktober 2009.
  • Jajah Fachiroh. New approaches for primary diagnosis and screening of nasopharyngeal carcinoma by using Epstein-Barr virus markers.
    Vrije Universiteit Amsterdam. 01 July 2009.
  • Serge J. Smeets. Genetic classification of head and neck cancer and hunting for the causative genes.
    Vrije Universiteit Amsterdam. 22 June 2009.
  • Pieter de Koning. The role of serpins and granzymes in cancer and immunity.
    Universiteit Utrecht. 02 Juni 2009.
  • M. Meleti. Pigmented lesions of the oral and head and neck mucosa, including malignant melanoma; a clinicopathologic study.
    Vrije Universiteit Amsterdam. 25 January 2008
  • K.H.N. de Boer. Thiopurine and IBD: pharmacology and toxicity.
    Vrije Universiteit Amsterdam. 11 November 2007
  • K.M. Lammers. Pouchitis, a model to study the pathogenesis of intestinal inflammation.
    Vrije Universiteit Amsterdam. 10 September 2004
  • F.J. Bikker. Salivary agglutinin; structure and function.
    Vrije Universiteit Amsterdam. 25 May 2004
  • M.P. Tabor. Second field tumors in head and neck cancer patients.
    Vrije Universiteit Amsterdam . 28 April 2004
  • S.L. Meijer. Tumor reactive T cells in clinical immunotherapy for the treatment of cancer.
    Vrije Universiteit Amsterdam. 27 February 2004
  • A. Dols. Immunotherapy strategies in breast cancer and melanoma.
    Vrije Universiteit Amsterdam. 27 Februari 2004
  • N.C.T. van Grieken. Morphological and chromosomal alterations during gastric carcinogenesis.
    Vrije Universiteit Amsterdam. 29 Oktober 2003
  • H.H.J. Backus. Thymidylate synthase inhibition: downstream effects and clinical implications for treatment of colorectal cancer.
    Vrije Universiteit Amsterdam. 27 June 2001